Biogen

News

Biogen gets FDA approval for ALS drug Qalsody

After much deliberation, the FDA has granted accelerated approval for Biogen’s tofersen for an ultra-rare form of the neurodegenerative disease amyotrophic lateral scleros

Patients

Reuters Pharma USA 2023 - Ligia del Bianco

Reuters Pharma USA – Ligia Del Bianco

At Reuters Pharma USA last month in Philadelphia, centring the voice of the patient was a major topic of discussion throughout the event.

News

Biogen buys into Denali’s amyloid beta programme

Biogen has taken up an option on a technology developed by Denali that it thinks could help improve the safety and efficacy of amyloid-targeting drugs for Alzheimer’s dise

News

FDA advisors will look at full Leqembi approval in June

The FDA has convened a meeting of an advisory committee in June to consider the bid by Eisai and Biogen to convert their accelerated approval of Alzheimer’s disease therap

News